Avadel Pharmaceuticals

NASDAQ: AVDL · Real-Time Price · USD
13.65
0.15 (1.11%)
At close: Aug 15, 2025, 11:14 AM

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending March 31, 2025, Avadel Pharmaceuticals generated $52.51M in revenue.
Revenue (ttm)
169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
899.56K
Employees
188
Market Cap
1.32B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.